Menopause Gut Health Connection: Why the Microbiome Matters for Hormone Balance and Symptom Relief
The Menopause Gut Health Connection: How the Microbiome Shapes Hormone Balance
Menopause is often framed as a story about estrogen alone. The reality is broader. As ovarian hormones decline, the gut microbiome shifts too, and the two appear to be linked closely enough that gut health has become part of the menopause conversation. Research in this area is growing quickly, with a mix of strong human studies and earlier mechanistic and animal work, so this article tries to be clear about what is well supported and what is still emerging.
Estrogen appears to support several aspects of gut health, including mucus production, tight junction stability, and a more diverse microbial community. Much of that detail comes from animal and mechanistic studies, while human research increasingly shows that the menopausal transition is associated with measurable changes in the gut microbiome (Baker et al., 2017, Maturitas: PubMed).
If you are researching an Akkermansia muciniphila supplement in this context, it helps to see Akkermansia as one mucus-associated species within a larger system involving the gut barrier, microbial diversity, and hormone-related microbial activity, rather than a menopause remedy on its own.

Quick Answers
Does menopause change the gut microbiome? Human studies suggest it does. As estrogen falls, the postmenopausal gut microbiome tends to shift, including changes in bacteria and microbial functions tied to estrogen processing.
What is the estrobolome? It is the set of gut microbial genes, especially those producing beta-glucuronidase, that influence how estrogen is recycled and reabsorbed. The term was introduced by Plottel and Blaser in 2011.
Can supporting gut health help with menopause? It may be one useful part of a broader plan alongside diet, stress management, sleep, and medical care. It is not a replacement for evaluation or treatment by a clinician.
How Menopause and Estrogen Interact With the Gut
Estrogen and gut bacteria influence each other. A review of this relationship describes how estrogen and the microbiota may act together in metabolism and related processes (Chen and Madak-Erdogan, 2016, Trends in Endocrinology & Metabolism: journal). As estrogen declines during menopause, it is plausible that gut barrier function and inflammatory balance shift as well, though the strength of evidence varies by outcome and much of the barrier-specific work is preclinical.
Hormone Balance and the Estrobolome
A useful concept here is the estrobolome, the collection of gut bacteria and genes that metabolize and recycle estrogens. Plottel and Blaser introduced this idea, proposing that microbial enzymes such as beta-glucuronidase can reactivate estrogen in the gut and influence how much circulates in the body (Plottel and Blaser, 2011, Cell Host & Microbe: journal). Because of this biology, menopause approaches that ignore the gut may miss part of the picture, even when hormones or botanicals are involved.
Human Evidence: Menopause and Microbiome Change
The strongest recent evidence comes from large human cohorts. In a study of about 2,300 Hispanic and Latino adults, postmenopausal women showed an altered gut microbiome and estrobolome compared with premenopausal women, including lower abundance of Akkermansia muciniphila and reduced microbial beta-glucuronidase activity, and these changes were associated with cardiometabolic risk markers (Peters et al., 2022, mSystems: journal). Smaller studies add detail in specific groups. For example, research in postmenopausal women with osteoporosis and osteopenia found genus-level microbiome differences linked to bone health, although overall diversity did not differ significantly between groups (Ji et al., 2024, PeerJ: PubMed).
This is also why some readers exploring broader topics such as the gut barrier and leaky gut become interested in menopause-related microbiome changes.

Circadian Rhythm and the Microbiome
The gut microbiome also follows daily rhythms. Foundational laboratory work in mice showed that gut microbes oscillate over the day in ways that coordinate host metabolism (Thaiss et al., 2014, Cell). Circadian disruption is one more factor that may interact with sleep, inflammation, and hormone timing during menopause, though the human evidence connecting this specifically to menopause symptoms is still developing.
Where Supplements Fit
A supplement works best as one part of a broader approach, not in isolation. Some menopause formulas now pair botanical ingredients with prebiotics so they support beneficial microbes rather than acting on hormones alone. One example is Vellura, a menopause-focused herbal supplement that combines botanicals with a prebiotic blend. Like any supplement, it is best viewed as a possible complement to diet, lifestyle, and medical care rather than a guaranteed source of relief.

It also helps to understand the difference between prebiotics and probiotics: probiotics introduce or support beneficial microbes, while prebiotics feed them.
A Systems View of Menopause
Menopause touches several connected systems at once: the gut microbiome, immune signaling, hormone metabolism, stress physiology, and sleep. Framing relief as restoring balance across these systems, rather than chasing single symptoms, is a reasonable way to think about it. That said, individual experiences vary widely, and a systems view is a complement to medical care, not a substitute for it. For a structured overview of the related articles, visit the Menopause & Gut Health: Complete Science Hub.
Frequently Asked Questions
1. How does menopause affect gut health?
As estrogen declines, the gut microbiome tends to shift, and human studies link menopause with changes in microbial composition and estrogen-processing activity. Some research also suggests gut permeability and inflammation may rise, though the strength of that evidence varies.
2. What is the estrobolome?
It is the collection of gut bacteria and genes, especially those producing beta-glucuronidase, that metabolize and recycle estrogens and help shape how much estrogen circulates.
3. Can gut health influence menopause symptoms like hot flashes and mood swings?
It may play a role through gut-brain, inflammation, sleep, and hormone-signaling pathways, but this is an area of active research rather than settled fact, and responses differ between individuals.
4. Why do menopause symptoms vary so much between women?
Differences in microbiome composition, immune tone, stress physiology, metabolic health, and lifestyle all contribute, not estrogen levels alone.
5. Can menopause symptoms be managed without hormone replacement therapy?
For some women, lifestyle, stress management, and gut-focused strategies may ease certain symptoms, but this varies widely. Decisions about hormone therapy are best made with a clinician who knows your history.
6. Why do some menopause supplements underperform?
Products that target hormones alone may overlook gut health, inflammation, and stress, which are part of the broader picture. No supplement works the same way for everyone.
7. How is gut health connected to hormone balance during menopause?
Gut bacteria influence estrogen recycling through the estrobolome. When the microbiome shifts, that recycling can change, which may affect circulating hormone levels.
8. Can the microbiome affect long-term postmenopausal health?
It appears connected to metabolic, immune, cardiovascular, and bone health, which is why postmenopausal gut changes are an active research focus.
9. Does menopause increase gut inflammation?
Declining estrogen may be associated with reduced gut barrier support and higher inflammatory signaling in some studies, though findings vary and much detail comes from preclinical work.
10. Can gut health influence menopause-related weight changes?
Microbiome shifts may affect insulin sensitivity, energy metabolism, and inflammation. This is best understood as one contributing factor rather than a stand-alone explanation.
11. Are menopause-related gut changes permanent?
Not necessarily. The microbiome stays dynamic and responsive to diet, lifestyle, and other inputs over time.
12. How does stress interact with gut health during menopause?
Stress hormones such as cortisol can affect gut barrier function, microbial balance, and inflammation, which may influence how symptoms are experienced.

References
-
Baker JM, Al-Nakkash L, Herbst-Kralovetz MM.
Estrogen-gut microbiome axis: Physiological and clinical implications.
Maturitas 2017;103:45-53. DOI. -
Chen KL, Madak-Erdogan Z.
Estrogen and Microbiota Crosstalk: Should We Pay Attention?
Trends in Endocrinology & Metabolism 2016;27(11):752-755. -
Plottel CS, Blaser MJ.
Microbiome and Malignancy (the paper that introduced the estrobolome concept) Cell Host & Microbe 2011;10(4):324-335. -
Thaiss CA, Zeevi D, Levy M, et al.
Transkingdom Control of Microbiota Diurnal Oscillations Promotes Metabolic Homeostasis.
Cell. 2014;159(3):514-529. (Foundational mouse study on microbiota daily rhythms.) DOI. -
Peters BA, Lin J, Qi Q, et al.
Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of Latinos.
mSystems. 2022;7(3):e0027322. DOI. -
Ji J, Gu Z, Li N, et al.
Gut microbiota alterations in postmenopausal women with osteoporosis and osteopenia from Shanghai, China.
PeerJ. 2024;12:e17416. DOI.
Written by Ali Rıza Akın
Microbiome Scientist, Author & Founder of Next-Microbiome
Ali Rıza Akın is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation.
His work focuses on how microbial ecosystems interact with human physiology, including:
-
Gut barrier function and intestinal permeability
-
Mucus-associated microbiota (Akkermansia-related systems)
-
Oral–gut microbiome axis
-
Short-chain fatty acids (SCFAs) and metabolic signaling
-
Circadian rhythm–microbiome interactions
-
Clinical Research Contributions
He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including:
Active Ulcerative Colitis (Inflammatory Bowel Disease)
Hyperoxaluria (Oxalate Metabolism Disorder)
Microbiome-driven gut health and inflammatory conditions
These studies were part of broader clinical development programs evaluating microbiome-based approaches. His contributions focused on the early-stage scientific and translational pipeline, including strain discovery, functional optimization, and multi-strain formulation design.
Scientific Contributions:
Ali Rıza Akın is the discoverer of Christensenella californii, a bacterial species associated with microbiome diversity and metabolic health.
He is a contributing author to scientific publications and Bacterial Therapy of Cancer (Springer), and the author of Bakterin Kadar Yaşa: İçimizdeki Evren: Mikrobiyotamız.
Approach:
His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health.
Medical Disclaimer
This content is for educational and informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any condition. Dietary supplements are not a substitute for prescription medication or professional care, and they do not replace evaluation or treatment for menopause, including decisions about hormone therapy. Consult a qualified healthcare professional before making changes to your diet, supplement routine, or treatment, especially if you are managing a health condition or taking medication.